Clinical Trials Logo

Clinical Trial Summary

A randomized, controlled, three-arm trial to investigate the effects of warm water footbaths with and without the addition of ginger or mustard powder on psychosocial parameters in patients with an oncological disease and in healthy controls.


Clinical Trial Description

A randomized, controlled trial with cross-over design in which the subjects (23 patients with an oncological disease, 13 healthy controls) receive warm water footbaths with added ginger (experimental) or mustard powder (experimental) or without additives (active comparator). The wash-out period between two consecutive footbath interventions is at least one day. Outcome measures are assessed right before (t1), right after (t2) and 10 minutes following the footbath (t3). The main focus is on the change in subjective perception of warmth distribution between t1 and t3. Moreover, the objective skin temperature distribution and psychosocial scores are assessed. The primary outcome measure is analyzed with a linear mixed effects model (after checking for carry-over effects). Secondary outcome measures are described descriptively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04271670
Study type Interventional
Source ARCIM Institute Academic Research in Complementary and Integrative Medicine
Contact
Status Completed
Phase N/A
Start date January 15, 2016
Completion date September 18, 2017

See also
  Status Clinical Trial Phase
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT01210716 - Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device Phase 3
Completed NCT05478733 - Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology
Terminated NCT03978312 - Nutrition Health Literacy of Cancer Patients and Their Support Networks.
Not yet recruiting NCT04142463 - Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2 N/A
Recruiting NCT06229535 - The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)
Completed NCT04420039 - Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction
Completed NCT03416465 - Place of General Medical During Oncology Care Management
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Completed NCT02484053 - Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders Early Phase 1
Completed NCT03030248 - Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients Phase 2
Not yet recruiting NCT03168048 - Oncologic Therapy Support Via Means of a Dedicated Mobile App N/A
Completed NCT03426553 - Clinical Use of Pathogen Reduced Red Blood Cell Suspension Phase 3
Active, not recruiting NCT04842214 - Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
Completed NCT03272646 - Prognostic Performance of the Naples Prognostic Score N/A
Terminated NCT02285296 - The Needs and Burden of Family Caregivers of Older Adults With Cancer N/A
Completed NCT04918888 - COVID-19 Vaccination in Oncologic Patients
Recruiting NCT05769868 - Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments Phase 3